Plasma Cell Neoplasms
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of Ninlaro in Real World Clinical Practice in China
A completed real-world study evaluating Ninlaro (ixazomib) in Chinese clinical practice for multiple myeloma. The study analyzes how the dru…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]
A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hemat…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with busulfan and fludarabine, with or without antithymocyte globulin, followed by d…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating rasburicase to prevent graft-versus-host disease in patients undergoing donor stem cell transplantation; the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Phase 3]
Phase 3 trial evaluating cyclosporine eye drops to prevent eye graft-versus-host disease in patients after donor stem cell transplant for he…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
SWOG's S0334 trial, which analyzes chromosomal abnormalities in patients with newly diagnosed multiple myeloma and other blood diseases, has…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer [Phase 1]
Phase 1 clinical trial update reporting the completion of a study of EMD 121974 in patients with various locally advanced or metastatic canc…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
The clinical trial evaluating blood stem cell transplants in adults and children with various hematologic cancers, sponsored by Columbia Uni…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 study evaluating liposomal doxorubicin, bortezomib, and dexamethasone in newly diagnosed multiple myeloma; the current trial statu…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood and placental blood transplantation for hematologic cancers or aplastic anemia. The s…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation [Phase 1]
Phase 1 study of a partially HLA-matched irradiated allogeneic cellular therapy given after reduced-intensity total body irradiation; the tr…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Rituximab in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating rituximab for multiple myeloma and related plasma cell neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [Phase 2]
A phase 2 clinical trial evaluating a biological therapy after chemotherapy and peripheral stem cell transplantation in patients with variou…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [Phase 1, Phase 2]
This Phase 1/2 trial evaluates a combination chemotherapy regimen followed by peripheral stem cell transplantation in patients with refracto…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial assessing T-cell-depleted allogeneic stem cell transplantation after immunoablative induction chemotherapy and reduced-intensi…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma [Phase 1]
A Phase 1 clinical trial update evaluating the combination of antithymocyte globulin and sirolimus in patients with relapsed multiple myelom…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer [Phase 2]
This is a Phase II clinical trial evaluating an umbilical cord blood transplant using fludarabine, melphalan, and anti-thymocyte globulin in…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 clinical trial results for a cyclophosphamide, bortezomib, and dexamethasone regimen in newly diagnosed multiple myeloma are reporte…
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil [NA]
This clinical trial update reports termination of a study evaluating tacrolimus with mycophenolate mofetil for graft-versus-host disease pro…
-
CLINICAL_TRIALS trial_result · 2010-05-13Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 2]
A Phase 2 trial evaluating tacrolimus and mycophenolate mofetil to prevent acute graft-versus-host disease in patients with advanced hematol…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating cyclophosphamide and/or mycophenolate mofetil with or without tacrolimus in patients undergoing donor bone…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [Phase 1]
This Phase 1 trial evaluating 12-O-tetradecanoylphorbol-13-acetate in hematologic cancers and bone marrow disorders was terminated.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 3]
This is a Phase 3 trial evaluating combination chemotherapy with or without idarubicin followed by peripheral stem cell transplantation in p…